Media coverage      Factsheet      Press releases      Company profile      

Send by emailPrint this page

29 May 2013: FierceBiotech – GlaxoSmithKline bags genetic vaccine developer Okairos for $325 million

29 May 2013: Bloomberg – Glaxo buys Okairos for $324 million to grow in vaccines

29 May 2013: The Wall Street Journal – GlaxoSmithKline buys Swiss vaccines firm

19 September 2012 FierceBiotech – Okairos: 2012 Fierce 15

15 Mar 2012 FierceVaccines - Hep C vaccine heads into further clinical trials

14 Mar 2012 FierceBiotech - Okairos launches pioneering mid-stage study of promising hep C vaccine

14 Mar 2012 Bloomberg - Former Merck unit works on first vaccine for hepatitis C

27 Feb 2012 NewsRx.com - Studies from M.G. Cottingham and colleagues provide new data on gene therapy

9 Feb 2012 Il Denaro - Napoli fabbrica i vaccini del futuro

27 Jan 2012 Il Venerdì di Repubblica - Il primo vaccino al mondo contro l'epatite C è una scommessa italiana

9 Jan 2012 European Biotechnology News - Chimp viruses as a vector for human vaccines

5 Jan 2012 FierceBiotech - Merck spinout nails promising study on hep C vaccine

4 Jan 2012 Science Translational Medicine – Podcast: In conversation with Okairos’ chief scientific officer Dr Alfredo Nicosia

4 Jan 2012 Reuters - Experimental hepatitis C vaccine shows early promise

4 Jan 2012 The Scientist - Chimp viruses for human vaccines

17 May 2011 L'Espresso - Qui c'è un po' d'America

7 April 2011 Life Sciences - Die Hoffnungsträger der Schweizer Biotech-Szene

30 Nov 2010 La Repubblica - Cortese: i vaccini del futuro

23 Nov 2010 Nicola Zingaretti

23 Nov 2010 Il Sole 24 Ore - A Pomezia i fondi Gates

7 June 2010 Corriere Economia - Il Craig Venter italiano? E' Cortese